Search companies

Live

Tuesday, 17 November 2026 · 580 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Bio-Gene Targets Flavocide Regulatory Filing As Japan Qcide Preparations Advance

BGT: $0.014 +7.69% · MC: $7M

Bio-Gene says it is targeting an initial Australian regulatory application for Flavocide in the second quarter of 2027, subject to completing studies and preparing the submission; draft reports for two key toxicity studies are under review. Work with Sumitomo and Nakashima on documentation and product development for Qcide supply to Japan continues, but timing for a first commercial order has not been agreed. The company also reported approximately $3 million in gross proceeds from its placement and share purchase plan, and received an R&D tax incentive of approximately $343,000 after quarter-end.

Source announcements: 2026-10-30 09:16 to 2026-10-30 11:22 Sydney time
Story updated 2026-10-30 11:26 Sydney time
SourcesNotice of Annual General Meeting/Proxy FormQuarterly Activities/Appendix 4C Cash Flow Report
Comments